Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Arsenic trioxide in acute promyelocytic leukemia: potion not poison.

Powell BL.

Expert Rev Anticancer Ther. 2011 Sep;11(9):1317-9. doi: 10.1586/era.11.128. Review. No abstract available.

PMID:
21929304
2.

[Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia].

Lengfelder E, Schultheis B, Büchner T, Hehlmann R.

Dtsch Med Wochenschr. 2007 Feb 16;132(7):330-6. Review. German. No abstract available.

PMID:
17286223
3.

Arsenic trioxide for the treatment of acute promyelocytic leukemia.

Lam MS, Ignoffo RJ.

Cancer Pract. 2001 May-Jun;9(3):155-7. No abstract available.

PMID:
11879303
4.

Advances in management of acute promyelocytic leukemia with arsenic trioxide.

Ma J.

Chin J Integr Med. 2007 Jun;13(2):92-4. No abstract available.

PMID:
17609904
5.

Arsenic trioxide in the treatment of relapsed and refractory acute promyelocytic leukemia.

Asou N.

Intern Med. 2005 Aug;44(8):775-6. No abstract available.

6.

Arsenic trioxide newly joins treatment strategies for acute promyelocytic leukemia.

Kuriyama K.

Intern Med. 2001 Dec;40(12):1165. No abstract available.

7.

Clinical usefulness of arsenic trioxide in the treatment of acute promyelocytic leukemia.

Lo Coco F.

Haematologica. 2002 May;87(5):452-3. No abstract available.

8.

Use of arsenic trioxide as a first-line single agent in the treatment of acute promyelocytic leukemia.

Keyhani M.

J Clin Oncol. 2012 Jan 10;30(2):217; author reply 218-20; discussion 220-2. doi: 10.1200/JCO.2011.38.7654. Epub 2011 Nov 28. No abstract available.

9.

Arsenic trioxide and acute promyelocytic leukemia: clinical and biological.

Chen Z, Zhao WL, Shen ZX, Li JM, Chen SJ, Zhu J, Lallemand-Breittenbach V, Zhou J, Guillemin MC, Vitoux D, de Thé H.

Curr Top Microbiol Immunol. 2007;313:129-44. Review.

PMID:
17217042
10.

Arsenic--new life for an old potion.

Gallagher RE.

N Engl J Med. 1998 Nov 5;339(19):1389-91. No abstract available.

PMID:
9801402
11.

[Arsenic trioxide as a therapeutic agent in APL].

Emi N.

Nihon Rinsho. 2007 Jan 28;65 Suppl 1:724-8. Review. Japanese. No abstract available.

PMID:
17474483
12.

[Pharmacological and clinical properties of arsenic trioxide (Trisenox) for relapse or refractory acute promyelocytic leukemia therapy].

Tajima M.

Nihon Yakurigaku Zasshi. 2005 Jun;125(6):389-96. Review. Japanese. No abstract available.

PMID:
16079563
13.

Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies.

Tallman MS.

Blood Rev. 2001 Sep;15(3):133-42. Review. No abstract available.

PMID:
11735161
14.

Unusual manifestations of acute leukemia. Case 1. CNS extramedullary relapse of acute promyelocytic leukemia after arsenic trioxide-induced remission.

Au WY, Ma SK, Ooi C, Liang R, Kwong YL.

J Clin Oncol. 2000 Oct 1;18(19):3435-7. No abstract available.

PMID:
11013284
15.

[Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine].

Haanen C, Vermes I.

Ned Tijdschr Geneeskd. 1999 Aug 21;143(34):1738-41. Review. Dutch.

PMID:
10494320
16.

[Arsenic trioxide treatment in a patient with recurrent acute promyelocytic leukemia (APL)].

Moreno Tejero ML, Lassaletta Atienza A, García Salido A, Sevilla Navarro J, Madero López L.

An Pediatr (Barc). 2010 Jul;73(1):39-41. doi: 10.1016/j.anpedi.2010.04.010. Epub 2010 Jun 4. Spanish.

17.

Arsenic trioxide treatment of relapsed acute promyelocytic leukaemia: initial Australian experience.

Spencer A, Firkin F.

Aust N Z J Med. 1999 Jun;29(3):385-6. No abstract available.

PMID:
10868510
18.
19.

Comparing two arsenic trioxide administration methods in APL therapy.

Zhou J, Meng R, Yang BF.

Chin Med J (Engl). 2004 Sep;117(9):1411-3. No abstract available.

PMID:
15377438
20.

Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide.

Hirayama Y, Koyama R, Nagai T, Ohta H, Kondo A, Ishikawa K, Ishitani K, Matsunaga T, Sakamaki S, Niitsu Y.

Intern Med. 2001 Nov;40(11):1136-9.

Items per page

Supplemental Content

Write to the Help Desk